AI Impact on Diabetes - BCC Pulse Report

September 2026 | 15 pages | ID: AA665C3BF9B4EN
BCC Research

Abstracts

This report covers the impact of AI on the diabetes market. It highlights the use of AI for early risk detection, personalized treatment planning, and continuous patient monitoring. AI is also being integrated into mobile health applications and wearable devices to support diet, physical activity, medication adherence, and day-to-day diabetes management.

Report Scope

AI is supporting new approaches to diabetes care through early detection, risk prediction, and personalized treatment. By analyzing clinical, glucose monitoring, lifestyle, and patient data, AI can support treatment planning, self-management, and continuous monitoring through digital health tools and wearable devices.

Report Includes

• Impact analysis of artificial intelligence (AI) on the global diabetes market
• Case studies for successful integration of AI and machine learning in early diagnosis, glucose monitoring, treatment optimization and patient management
• Highlights of AI adoption trends across major geographical regions, as well as disruptions caused by AI across key endocrinology, medical devices and digital health industry verticals
• AI’s role in personalized care, clinical decision support, disease management and patient engagement
• Review of AI impact on the various stages of the global diabetes value chain and supply chain analysis
• Competitive landscape featuring key strategic initiatives, market spendings and an investment outlook

Contents

CHAPTER 1 KEY USE CASES FOR AI ADOPTION IN DIABETES

Overview
Case Studies
Case 1: Diabetes Pharmaceuticals
Case 2: Glucose Monitoring Device Technologies
Case 3: Insulin Delivery Device Technologies

CHAPTER 2 AI ADOPTION TRENDS

Adoption Trends by Region
Adoption Trends in North America
Adoption Trends in Europe
Adoption Trends in Asia-Pacific
Adoption Trends in the Rest of the World

CHAPTER 3 AI DISRUPTION TRENDS

Impact of AI on Key Industry Verticals
Drug Discovery and Development
Glucose Monitoring
Insulin Delivery Systems
Impact of AI on Various Stages of the Supply Chain
Research and Development
Manufacturing
Demand Forecasting and Inventory Management
Patient Access

CHAPTER 4 MARKET SPENDING AND INVESTMENT SCENARIO

Overview
Market Spending and Forecasting Analysis
Market Spending and Forecasting Analysis
Key Spending by Diabetes Therapeutics and Diagnostics Companies on AI
VC Investment in AI Focused on Relevant Technologies and Products
VC Investments

CHAPTER 5 ABBREVIATIONS

Abbreviations Used in the Report

List Of Tables

LIST OF TABLES
Table 1 : Key Initiatives by Companies on AI, 2024–2026
Table 2 : Key Spending by Companies on AI-Based Diabetes Therapeutics and Diagnostics, 2024–2025
Table 3 : Abbreviations Used in This Report

List Of Figures

LIST OF FIGURES
Figure 1 : Impact of AI on Value Chain